New combo shows promise for hard-to-treat colorectal cancer in phase III trial
NCT ID NCT06791512
First seen Jan 05, 2026 · Last updated May 25, 2026 · Updated 29 times
Summary
This study tests whether adding an immunotherapy drug (PD-1 monoclonal antibody) and bevacizumab to standard chemotherapy helps shrink tumors before surgery in people with a specific type of advanced colorectal cancer (pMMR/MSS). About 166 participants will be randomly assigned to receive either the new combination or chemotherapy alone. The goal is to see if the combination leads to better outcomes, such as longer disease-free survival and higher chances of complete tumor removal.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER (CRC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Sixth Affiliated Hospital, Sun Yat-sen University
RECRUITINGGuangzhou, Guangdong, 510655, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.